MTNR1A receptor expression in normal and pathological human salivary glands

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4765-4772

  Arias Santiago, Salvador ^a   Aneiros Ferńandez, José ^a   Arias Santiago, Borja ^b   Giŕon Prieto, María Sierra ^a   Caba Molina, Mercedes ^a   López Valverde, Antonio ^c   Aneiros Cachaza, José ^a   Campos, Antonio ^a   Cutando, Antonio ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Melatonin; MTNR1A; Normal salivary glands

Indexed keywords

MELATONIN 1 RECEPTOR; MELATONIN 1A RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BASAL CELL; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH FOLLICLE; MUCOUS CELL; MYOEPITHELIUM CELL; PAROTID GLAND; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND; WARTHIN TUMOR;

ADENOLYMPHOMA; ADULT; AGED; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, MELATONIN, MT1; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872660462     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Claustrat B, Brun J and Chazot G: The basic physiology and pathophysiology of melatonin, Sleep Med Rev 9: 11-24, 2005.
2. Reiter RJ: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12: 151-180, 1991.
3. Reiter RJ: Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 17: 273-285, 2003.
4. Bubenik GA: Gastrointestinal melatonin, localization, function and clinical relevance. Dig Dis Sci 47: 2336-2348, 2002.
5. Raikhlin NT, Kvetnoy IM and Tolkachev VN: Melatonin may be synthesised in enterochromaffin cells. Nature 255: 344-345, 1975.
6. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ and Masana MI: Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8: 1093-1108, 2003.
7. Slaugenhaupt SA, Roca AL, Liebert CB, Gusella JF and Repert SM: Mapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (MTNR1A). Genomics 27: 355-357, 1995.
8. Reppert SM, Weaver DR and Godson C: Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 17: 100-102, 1996.
9. Vaněcek J: Melatonin binding sites. J Neurochem 51: 1436-1440, 1988.
10. Lissoni P, Tancini G, Barni S, Paolorossi F, Ardizzoia A, Conti A and Maestroni G: Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer 5: 126-129, 1997.
11. Hunt AE, Al-Ghoul WM, Gillette MU and Dubocovich ML: Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 280: 110-118, 2001.
12. Aras HC, Ekström J: Melatonin-evoked in vivo secretion of protein and amylase from the parotid gland of the anaesthetised rat. J Pineal Res 45: 413-421, 2008.
13. Shiu SY, Law IC, Lau KW, Tam PC, Yip AW and Ng WT: Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. J Pineal Res 35: 177-182, 2003.
14. Witt-Enderby PA, MacKenzie RS, McKeon RM, Caroll EA, Bordt SL and Melan MA: Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor. Cell Motil Cytoskeleton 46: 28-42, 2000.
15. Huether G: The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 49: 665-670, 1993.
16. Bubenik GA: Gastrointestinal melatonin, localization, function and clinical relevance. Dig Dis Sci 47: 2336-2348, 2002.
17. Sjoöblom M, Jedstedt G and Flemström G: Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. J Clin Invest 108: 625-633, 2001.
18. Jaworek J, Nawrot K, Konturek J, Leja-Szpak A, Thor P and Pawlik WW: Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 36: 155-164, 2004.
19. Li Y, Hoa Y and Owyang C: High affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 273: G679-G685, 1997.
20. Leja-Szpak A, Jaworek J, Nawrot-Porabka K, Palonek M, Mitis-Musioł M, Dembiński A, Konturek SJ and Pawlik WW: Modulation of pancreatic enzyme secretion by melatonin and its precursor; L-tryptophan. Role of CCK and afferent nerves. J Phys Pharm 55: 33-46, 2004.
21. Cutando A, Gomez-Moreno G, Villalba J, Ferrera MJ, Escames G and Acuna-Castroviejo D: Relationship between salivary melatonin levels and periodontal status in diabetic patients. J Pineal Res 35: 239-244, 2003.
22. Fischer TW, Sweatman TW, Semak I, Sayre RM, Wortsman J and Slominski A: Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 20: 1564-1566, 2006.
23. Barrett P, MacLean A, Davidson G and Morgan PJ: Regulation of the Mel 1a melatonin receptor mRNA and protein levels in the ovine pars tuberalis: Evidence for a cyclic adenosine 3′,5′- monophosphate-independent Mel 1a receptor coupling and an autoregulatory mechanism of expression. Mol Endocrinol 10: 892-902, 1996.
24. Dillon DC, Easley SE, Asch BB, Cheney RT, Brydon L, Jockers R, Winston JS, Brooks JS, Hurd T and Asch HL: Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 118: 451-458, 2002.
25. Cutando A, Aneiros-Fernández J, López-Valverde A, Arias-Santiago S, Aneiros-Cachaza J and Reiter RJ: A new perspective in oral health: Potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral Biol 56: 944-950, 2011.
26. Cutando A, Aneiros-Fernández J, Aneiros-Cachaza J and Arias-Santiago S: Melatonin and cancer: Current knowledge and its application to oral cavity tumours: J Oral Pathol Med 40: 593-597, 2011.
27. Cutando A, López-Valverde A, Arias-Santiago S, DE Vicente J and DE Diego RG: Role of melatonin in cancer treatment. Anticancer Res 32: 2747-2753, 2012.